Glioma Clinical Trials in New Brunswick, New Jersey

3 studies are recruiting for glioma in New Brunswick, New Jersey right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease

    This study will include up to 40 participants with Grade 2 or Grade 3 IDH1-mutant glioma who have undergone surgery and received vorasidenib as their only treatment, experienced radiographic disease progression on vorasidenib (confirmed by Blinded Independent Central Review [BICR] per modified Resp…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Rutgers Cancer Institute, New Brunswick, New Jersey
    Locations
    12 in total
    Run by
    Nuvation Bio Inc.

    See if you can join NCT07703436 on ClinicalTrials.gov

  2. SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

    This is a 3-part study. The purpose of Part 1 of the study is to evaluate the efficacy, safety, and pharmacokinetic (PK) characteristics of safusidenib in participants with recurrent/progressive IDH1-mutant World Health Organization (WHO) Grade 2 or Grade 3 glioma. The purpose of Part 2 will be to …

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Rutgers Cancer Institute, New Brunswick, New Jersey
    Locations
    61 in total
    Run by
    Nuvation Bio Inc.

    See if you can join NCT05303519 on ClinicalTrials.gov

  3. Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

    The purpose of this study is to see if combining silevertinib with temozolomide after surgery and radiotherapy helps treat newly diagnosed glioblastoma (GBM) better than using temozolomide alone in the maintenance setting. Specifically, this study is being done to find answers to the following ques…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Rutgers Cancer Institute, New Brunswick, New Jersey
    Locations
    34 in total
    Run by
    Black Diamond Therapeutics, Inc.

    See if you can join NCT07326566 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.